Effect of MK-801, an antagonist of NMDA receptor in the pedunculopontine tegmental nucleus, on cardiovascular parameters in normotensive and hydralazine hypotensive rats

Document Type : Original Article


1 Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran

2 Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

4 Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran



Objective(s): In the present study, the cardiovascular effects of glutamate NMDA receptor of the pedunculopontine tegmental nucleus (PPT) in normotensive and hydralazine (HLZ) hypotensive rats were evaluated. 
Materials and Methods: In the normotensive condition, MK-801(1 nmol; an NMDA receptor antagonist) and L-glutamate (L-Glu, 50 nmol an agonist) alone and together were microinjected into the nucleus using a stereotaxic device. In hypotensive condition, 2 min after induction of hypotension by HLZ (10 mg/kg, intravenous), drugs, same as in normotensive condition, were microinjected into the PPT. Recorded mean arterial pressure (MAP), systolic blood pressure (SBP), and heart rate (HR) were recorded throughout the experiment by a Power lab apparatus that was connected to a catheter inserted into the femoral arty. The cardiovascular changes (Δ) induced by microinjection drugs were computed and statistically analyzed.
Results: In the normotensive condition, L-Glu significantly increased ΔMAP and ΔSBP (P<0.001) and decreased ΔHR (P<0.01) compared with the control. MK-801 alone significantly increased HR (P<0.05) while co-injected with L-Glu + MK-801 it significantly attenuated the L-Glu effect on ΔMAP and ΔSBP but augmented ΔHR (P<0.01). In the hydralazine hypotension condition, L-Glu significantly improved hypotension (P<0.01) and deteriorated bradycardia induced by HLZ (P<0.05). MK-801 alone did not significantly affect ΔMAP, ΔSBP, and ΔHR but when co-injected with L-Glu (L-Glu + MK-801) it could significantly attenuate the cardiovascular effect of L-Glu in the PPT. 
Conclusion: We found that activation of NMDA receptors of the glutamatergic system in the PPT evoked blood pressure and inhibited HR in both normotensive and hypotensive conditions in rats. 


1.  Martinez-Gonzalez C, Bolam JP, Mena-Segovia J. Topographical organization of the pedunculopontine nucleus. Front Neuroanat 2011;5:22-32.
2. Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci 2004;27:585-588.
3. Alam M, Schwabe K, Krauss JK. The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation. Brain 2011;134:11-23.
4. Garcia-Rill E, Simon C, Smith K, Kezunovic N, Hyde J. The pedunculopontine tegmental nucleus: from basic neuroscience to neurosurgical applications. J Neural Transm 2011;118:1397-1407.
5. Jenkinson N, Nandi D, Muthusamy K, Ray NJ, Gregory R, Stein JF, et al. Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus. Mov Disord 2009;24:319-328.
6. Kang Y, Kitai S. Electrophysiological properties of pedunculopontine neurons and their postsynaptic responses following stimulation of substantia nigra reticulata. Brain Res 1990;535:79-95.
7. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 2006;248:234-250.
8. Garcia-Rill E. The pedunculopontine nucleus. Prog Neurobiol. 1991;36:363-389.
9. Garcia-Rill E, Saper C, Rye DB, Kofler M, Nonnekes J, Lozano A, et al. Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA. Clin Neurophysiol 2019;130:925-940.
10.    Kroeger D, Ferrari LL, Petit G, Mahoney CE, Fuller PM, Arrigoni E, et al. Cholinergic, glutamatergic, and GABAergic neurons of the pedunculopontine tegmental nucleus have distinct effects on sleep/wake behavior in mice. J Neurosci 2017;37:1352-1366.
11.    Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson’s disease. Brain 2000;123:1767-1783.
12.    Padley JR, Kumar NN, Li Q, Nguyen TB, Pilowsky PM, Goodchild AK. Central command regulation of circulatory function mediated by descending pontine cholinergic inputs to sympathoexcitatory rostral ventrolateral medulla neurons. Circul Res 2007;100:284-291.
13.    Dampney RA. Central neural control of the cardiovascular system: Current perspectives. Adv Physiol Educ 2016;40:283-296.
14.    Topchiy I, Waxman J, Radulovacki M, Carley DW. Functional topography of respiratory, cardiovascular and pontine-wave responses to glutamate microstimulation of the pedunculopontine tegmentum of the rat. Respir Physiol Neurobiol 2010;173:64-70.
15.    Shafei MN, Nikyar T, Hosseini M, Niazmand S, Paseban M. Cardiovascular effects of nitrergic system of the pedunculopontine tegmental nucleus in anesthetized rats. Iran J Basic Med Sci 2017;20:776-782.
16.    Shafei MN, Niazmand S, Hosseini M, Daloee MH. Pharmacological study of cholinergic system on cardiovascular regulation in the cuneiform nucleus of rat. Neurosci Lett 2013;549:12-7.
17.    Pasandi H, Abbaspoor S, Shafei MN, Hosseini M, Khajavirad A. GABA A receptor in the Pedunculopontine tegmental (PPT) nucleus: Effects on cardiovascular system. Pharmacol Rep 2018;70:1001-1009.
18.    Reiner A, Levitz J. Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert. Neuron. 2018;98:1080-1098.
19.    Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000;130:1007S-1015S.
20.    Basting T, Xu J, Mukerjee S, Epling J, Fuchs R, Sriramula S, et al. Glutamatergic neurons of the paraventricular nucleus are critical contributors to the development of neurogenic hypertension. The J Physiol 2018;596:6235-6248.
21.    Pyatin V, Tatarnikov V. NMDA receptors of A5 area in the regulation of blood pressure and respiratory activity during hypoxia in rats. Bull Exp Biol Med 2015;159:420-423.
22.    Maione S, Berrino L, Vitagliano S, Leyva J, Rossi F. Interactive role of L-glutamate and vasopressin, at the level of the PAG area, for cardiovascular tone and stereotyped behaviour. Brain Res 1992;597:166-169.
23.    Nasimi A, Shafei M, Alaei H. Glutamate injection into the cuneiform nucleus in rat, produces correlated single unit activities in the Kolliker-Fuse nucleus and cardiovascular responses. Neuroscience 2012;223:439-446.
24.    Alikhani V, Mohebbati R, Hosseini M, Khajavirad A, Shafei MN. Role of the glutamatergic system of ventrolateral periaqueductal gray (vlPAG) in the cardiovascular responses in normal and hemorrhagic conditions in rats. Iran J Basic Med Sci 2021;24:586-594.
25.    Mohebbati R, Hosseini M, Khazaei M, Rad AK, Shafei MN. Involvement of the 5-HT1A receptor of the cuneiform nucleus in the regulation of cardiovascular responses during normal and hemorrhagic conditions. Iran J Basic Med Sci 2020;23:858-864.
26.    Nikyar T, Hosseini M, Niazmand S, Shafei MN. Evaluation of nicotinic receptor of pedunculopontine tegmental nucleus in central cardiovascular regulation in anesthetized rat. Iran J Basic Med Sci 2018;21:376-381.
27.    Paxinos G. Rat Brain: In Stereotaxic Crdinats 2eppr: Academic press; 2012.
28.    Martin DS, Haywood JR. Sympathetic nervous system activation by glutamate injections into the paraventricular nucleus. Brain Res 1992;577:261-267.
29.    Zhang X-J, Xu M-Y, Lv N. Influence of glutamate and NMDA-receptor antagonist MK-801 on the electric activities of pain-excitation neurons in the nucleus accumbens of rats. Sheng li xue bao:[Acta physiologica Sinica]. 2005;57:66-70.
30.    Curtis KS, Cunningham JT, Heesch CMJAJoP-R, Integrative, Physiology C. Fos expression in brain stem nuclei of pregnant rats after hydralazine-induced hypotension. 1999;277:R532-R540.
31.    Busnardo C, Crestani CC, Tavares RF, Resstel LB, Correa FM. Cardiovascular responses to L-glutamate microinjection into the hypothalamic paraventricular nucleus are mediated by a local nitric oxide-guanylate cyclase mechanism. Brain Res 2010;1344:87-95.
32.    Mori F, Okada K-i, Nomura T, Kobayashi Y. The pedunculopontine tegmental nucleus as a motor and cognitive interface between the cerebellum and basal ganglia. Front Neuroanat 2016;10:109.
33.    Hamani C, Aziz T, Bloem BR, Brown P, Chabardes S, Coyne T, et al. Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical anatomy and terminology. Stereotact Funct Neurosurg 2016;94:298-306.
34.    Yasui Y, Cechetto DF, Saper CB. Evidence for a cholinergic projection from the pedunculopontine tegmental nucleus to the rostral ventrolateral medulla in the rat. Brain Res 1990;517:19-24.
35.    Takakusaki K, Shiroyama T, Yamamoto T, Kitai S. Cholinergic and noncholinergic tegmental pedunculopontine projection neurons in rats revealed by intracellular labeling. J Comp Neurol 1996;371:345-361.
36.    Ford B, Holmes CJ, Mainville L, Jones BE. GABAergic neurons in the rat pontomesencephalic tegmentum: codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J Comp Neurol 1995;363:177-196.
37.    Bohus B, Koolhaas JM, Korte SM, Roozendaal B, Wiersma A. Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat. Clin Exp Pharmacol Physiol 1996;23:177-182.
38.    Verberne A. Cuneiform nucleus stimulation produces activation of medullary sympathoexcitatory neurons in rats. Am J Physiol Regul Integr Comp Physiol 1995;268:R752-R758.
39.    Steininger TL, Rye DB, Wainer BH. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J Comp Neurol 1992;321:515-543.
40.    Mena‐Segovia J, Sims HM, Magill PJ, Bolam JP. Cholinergic brainstem neurons modulate cortical gamma activity during slow oscillations. J Physiol 2008;586:2947-2960.
41.    Karlsson GA, Preuss CV, Chaitoff KA, Maher TJ, Ally A. Medullary monoamines and NMDA-receptor regulation of cardiovascular responses during peripheral nociceptive stimuli. Neurosci Res 2006;55:316-326.
42.    Urban M, Gebhart G. Central mechanisms in pain. Med Clin North Am 1999;83:585-596.
43.    Carlson JD, Iacono RP, Maeda G. Nociceptive excited and inhibited neurons within the pedunculopontine tegmental nucleus and cuneiform nucleus. Brain Res. 2004;1013:182-187.
44.    Benarroch EE. Pedunculopontine nucleus: Functional organization and clinical implications. Neurology 2013;80:1148-1155.
45.    Sacco M, Meschi M, Regolisti G, Detrenis S, Bianchi L, Bertorelli M, et al. The relationship between blood pressure and pain. J Clin Hypertens 2013;15:600-605.